U.S. Patent and Trademark Office Publishes Novmetapharma Co Ltd, Seoul National University Hospital and Seoul National University R&DB Foundation's Patent Application for Use of Cyclo(His-Pro) (CHP) for Preventing, Alleviating or Treating Peritoneal Fibro

Press/Media: Press / Media

Period2022 Jun 27

Media coverage

1

Media coverage

  • TitleU.S. Patent and Trademark Office Publishes Novmetapharma Co Ltd, Seoul National University Hospital and Seoul National University R&DB Foundation's Patent Application for Use of Cyclo(His-Pro) (CHP) for Preventing, Alleviating or Treating Peritoneal Fibro
    Media name/outletGlobal IP News. Medical Patent News
    Country/TerritoryIndia
    Date22/6/27
    PersonsJong Hak Kim